Publications by authors named "Tomoko Higuchi"

Claim this Profile
C
Cosmetic outcomes of rotation flap and suture scaffold for breast-conserving therapy in the lower quadrants.
Tomohiko Aihara, Noriko Aritake, Michiko Imamura, Masatsugu Okishiro, Tomoko Higuchi

Breast Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan.
Yusa Togashi, Masayuki Nagahashi, Aoi Oshiro, Gen Sugimoto, Ayumu Mitsuyoshi, Tomoko Higuchi

Int J Clin Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.
Masayuki Nagahashi, Eri Ishikawa, Takahiro Nagai, Haruka Kanaoka, Aoi Oshiro, Tomoko Higuchi

Breast Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant Chemotherapy.
Aoi Oshiro, Masayuki Nagahashi, Yusa Togashi, Haruka Kanaoka, Akira Hattori, Tomoko Higuchi

Anticancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.
Ayumu Mitsuyoshi, Masayuki Nagahashi, Haruka Kanaoka, Aoi Oshiro, Yusa Togashi, Tomoko Higuchi

Int J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study.
Tomoko Higuchi, Tomomi Ueno, Shigeto Uchiyama, Shunji Matsuki, Mariko Ogawa

BMC Complement Med Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between FDG-PET and the immune microenvironment in breast cancer.
Kazuhiro Kitajima, Tomoko Higuchi, Yukie Fujimoto, Eri Ishikawa, Hiroyuki Yokoyama

Eur J Radiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor.
Hiromi Ozawa, Tomoko Higuchi, Yukie Fujimoto, Ayako Bun, Reiko Fukui

Anticancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Haruka Kanaoka, Masayuki Nagahashi, Yusa Atake, Akira Hattori, Ayako Bun, Tomoko Higuchi

Anticancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early assessment of tumor response using F-FDG PET/CT after one cycle of systemic therapy in patients with recurrent and metastatic breast cancer.
Kazuhiro Kitajima, Tomoko Higuchi, Koichiro Yamakado, Yasuo Miyoshi

Hell J Nucl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Versican contributes to ligament formation of knee joints.
Tomoko Higuchi, Daisuke Suzuki, Takafumi Watanabe, Kanda Fanhchaksai, Keiko Ota

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin.
Atsushi Sata, Reiko Fukui, Yoshimasa Miyagawa, Ayako Bun, Hiromi Ozawa, Tomoko Higuchi

Anticancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes.
Ayako Bun, Yukie Fujimoto, Tomoko Higuchi, Atsushi Sata, Reiko Fukui

Anticancer Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between FOXP3/CD8 Lymphocyte Ratios and Tumor Infiltrating Lymphocyte Levels in Different Breast Cancer Subtypes.
Reiko Fukui, Yukie Fujimoto, Takahiro Watanabe, Natsuko Inoue, Ayako Bun, Tomoko Higuchi

Anticancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.
Yoshimasa Miyagawa, Ayako Yanai, Takehiro Yanagawa, Junichi Inatome, Chiyomi Egawa, Tomoko Higuchi

Oncotarget· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
Yukie Fujimoto, Takahiro Watanabe, Akira I Hida, Tomoko Higuchi, Yoshimasa Miyagawa

Breast Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.
Hiromi Ozawa, Atsushi Sata, Reiko Fukui, Ayako Bun, Tomoko Higuchi

Anticancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy.
Tomoko Higuchi, Yukie Fujimoto, Hiromi Ozawa, Ayako Bun, Reiko Fukui

Ann Surg Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prognosis of low baseline neutrophil-to-lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes.
Yukie Fujimoto, Hiromi Ozawa, Tomoko Higuchi, Yoshimasa Miyagawa, Ayako Bun

Mol Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine.
Michiko Imamura, Takashi Morimoto, Chiyomi Egawa, Reiko Fukui, Ayako Bun, Tomoko Higuchi

Sci Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
Yoshimasa Miyagawa, Kazuhiro Araki, Ayako Bun, Hiromi Ozawa, Yukie Fujimoto, Tomoko Higuchi

Clin Breast Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual oral mucosal microbiota after hematopoietic cell transplantation with glycopeptide antibiotics: potential association with pathophysiology of oral mucositis.
Misato Muro, Yoshihiko Soga, Tomoko Higuchi, Kota Kataoka, Daisuke Ekuni

Folia Microbiol (Praha)· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
Yukie Fujimoto, Tomoko Higuchi, Arisa Nishimukai, Yoshimasa Miyagawa, Ayako Kira

J Surg Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw.
Tomoko Higuchi, Yoshihiko Soga, Misato Muro, Makoto Kajizono, Yoshihisa Kitamura

Oral Surg Oral Med Oral Pathol Oral Radiol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of tumor response to neoadjuvant chemotherapy in patients with breast cancer using MRI and FDG-PET/CT-RECIST 1.1 vs. PERCIST 1.0.
Kazuhiro Kitajima, Yasuo Miyoshi, Toshiko Yamano, Soichi Odawara, Tomoko Higuchi

Nagoya J Med Sci· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis